News | January 06, 2025
Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Designation was based on early efficacy data demonstrating an 83.3% (10/12) overall response rate and a 50% (6/12) complete response rate, with a well-managed safety profile in Relapsed/Refractory Hodgkin Lymphoma patients
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Q2 FY25 Total Income was at Rs. 85.4 crore
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Subscribe To Our Newsletter & Stay Updated
